Literature DB >> 8225594

Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines.

P Ringwald1, F Peyron, J P Lepers, P Rabarison, C Rakotomalala, M Razanamparany, M Rabodonirina, J Roux, J Le Bras.   

Abstract

To determine virulence factors of isolates of Plasmodium falciparum and the potential role of cytokines in cerebral malaria, 46 Malagasy patients presenting with cerebral (n = 10), severe (n = 10), and uncomplicated (n = 26) malaria were enrolled in a study. The capacity of 21 of 46 P. falciparum isolates to form rosettes in vitro and to adhere to human umbilical vein endothelial cells (HUVECs) that express intercellular adhesion molecule-1 receptors and to C32 amelanotic melanoma cells that express mainly CD36 receptors was investigated together with the effects of tumor necrosis factor alpha (TNF-alpha), granulocyte macrophage-colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-6 alone and in two-by-two combinations on the cytoadherence of infected erythrocytes to HUVECs. Plasma levels of these cytokines were also measured in the patients at admission. The percentage of rosette formation was higher for the isolates from patients with cerebral (n = 6; 19.5%) and severe (n = 6; 30.5%) malaria than for those from patients with uncomplicated malaria (n = 9; 5%) (P < 0.002). The cytoadherence properties of the isolates did not differ among the three groups whatever the target cell used, but adherence to melanoma cells was systematically higher than that to HUVECs. Adhesion to HUVECs was increased more after TNF-alpha stimulation than after GM-CSF, IL-3, or IL-6 stimulation (P < 0.01). Only the combination of TNF-alpha and IL-3 enhanced cytoadherence more than TNF-alpha used alone (P < 0.02). No difference in the modulation of cytoadherence by cytokines was found in relation to the severity of the disease. TNF-alpha and IL-6 levels in peripheral blood were higher in the patients with cerebral and severe malaria than in the patients with uncomplicated malaria (P < 0.005). Most of the patients' sera contained little or no IL-3 or GM-CSF. Our results challenge the role of intercellular adhesion molecule-1 as the principal receptor mediating the cytoadherence of P. falciparum-infected erythrocytes and contrast with data obtained in the murine model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225594      PMCID: PMC281301          DOI: 10.1128/iai.61.12.5198-5204.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  An in vitro assay for sequestration: binding of Plasmodium falciparum-infected erythrocytes to formalin-fixed endothelial cells and amelanotic melanoma cells.

Authors:  I J Udeinya; J Leech; M Aikawa; L H Miller
Journal:  J Protozool       Date:  1985-02

2.  Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.

Authors:  P Kern; C J Hemmer; J Van Damme; H J Gruss; M Dietrich
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

3.  Cytoadherence characteristics of rosette-forming Plasmodium falciparum.

Authors:  R Udomsangpetch; H K Webster; K Pattanapanyasat; S Pitchayangkul; S Thaithong
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  Plasmodium falciparum: cytoadherence of malaria-infected erythrocytes to human brain capillary and umbilical vein endothelial cells--a comparative study of adhesive ligands.

Authors:  H Smith; J A Nelson; C G Gahmberg; I Crandall; I W Sherman
Journal:  Exp Parasitol       Date:  1992-11       Impact factor: 2.011

5.  Cerebral malaria. A disseminated vasculomyelinopathy.

Authors:  G Toro; G Román
Journal:  Arch Neurol       Date:  1978-05

6.  Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells.

Authors:  R A Swerlick; K H Lee; L J Li; N T Sepp; S W Caughman; T J Lawley
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

7.  Plasmodium falciparum: inhibition/reversal of cytoadherence of Thai isolates to melanoma cells by local immune sera.

Authors:  B Singh; M Ho; S Looareesuwan; E Mathai; D A Warrell; M Hommel
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

8.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

9.  Clinical correlates of in vitro Plasmodium falciparum cytoadherence.

Authors:  M Ho; B Singh; S Looareesuwan; T M Davis; D Bunnag; N J White
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia.

Authors:  G E Grau; K Frei; P F Piguet; A Fontana; H Heremans; A Billiau; P Vassalli; P H Lambert
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  35 in total

1.  Variable var transition rates underlie antigenic variation in malaria.

Authors:  Paul Horrocks; Robert Pinches; Zóe Christodoulou; Sue A Kyes; Chris I Newbold
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

2.  Plasmodium falciparum: Rosettes do not protect merozoites from invasion-inhibitory antibodies.

Authors:  Anne-Marie Deans; J Alexandra Rowe
Journal:  Exp Parasitol       Date:  2005-12-20       Impact factor: 2.011

Review 3.  Host-parasite interaction and morbidity in malaria endemic areas.

Authors:  K Marsh; R W Snow
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

4.  CR1 Knops blood group alleles are not associated with severe malaria in the Gambia.

Authors:  P A Zimmerman; J Fitness; J M Moulds; D T McNamara; L J Kasehagen; J Alexandra Rowe; A V S Hill
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

5.  Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.

Authors:  J Alexandra Rowe; Ian G Handel; Mahamadou A Thera; Anne-Marie Deans; Kirsten E Lyke; Abdoulaye Koné; Dapa A Diallo; Ahmed Raza; Oscar Kai; Kevin Marsh; Christopher V Plowe; Ogobara K Doumbo; Joann M Moulds
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

6.  Inhibition of Plasmodium falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: therapeutic implications for severe malaria.

Authors:  Estelle S Zang-Edou; Ulrick Bisvigou; Zacharie Taoufiq; Faustin Lékoulou; Jean Bernard Lékana-Douki; Yves Traoré; Dominique Mazier; Fousseyni S Touré-Ndouo
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

7.  Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria.

Authors:  Pamela A Magistrado; John Lusingu; Lasse S Vestergaard; Martha Lemnge; Thomas Lavstsen; Louise Turner; Lars Hviid; Anja T R Jensen; Thor G Theander
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

Review 8.  Virulence evolution in response to vaccination: the case of malaria.

Authors:  M J Mackinnon; S Gandon; A F Read
Journal:  Vaccine       Date:  2008-07-18       Impact factor: 3.641

9.  Comparative transcriptional and genomic analysis of Plasmodium falciparum field isolates.

Authors:  Margaret J Mackinnon; Jinguang Li; Sachel Mok; Moses M Kortok; Kevin Marsh; Peter R Preiser; Zbynek Bozdech
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

Review 10.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.